ILUMIEN-V - AERO STUDY
With the approval of the principal ethics committee in Germany, another important milestone has been achieved for the Institute for Myocardial Infarction Research.
Read moreYour data is ready. It has been checked, cleaned up and is now in a standardised format. We evaluate your data together with you. You ask the questions and we provide the analysis.
You can rely on the quality of your data and your results.
We work together with you on your presentations and publications. You can rely on us in review processes too. We are experts in the field and we specialise in cardiovascular diseases. We are able to work closely with you to provide fast responses, check everything one last time and answer any remaining questions.
We’ll also work late into the night to do this when necessary.
We congratulate you and celebrate with you. And we are already looking forward to your next idea.
With the approval of the principal ethics committee in Germany, another important milestone has been achieved for the Institute for Myocardial Infarction Research.
Read moreFirst results introduced during the 88th annual meeting of the DGK in Mannheim byProf. Uwe Zeymer, Chairman of the Foundation Institute for Myocardial Infarction Research and Principal Investigator of the GULLIVE-R study.
Read moreDr. Matthieu Godin and his study team from Clinique Saint Hilaire in Rouen, and Dr. Christophe Robin and his study team from Clinique Convert, of Bourg en Bresse are pleased to announce the successful enrollment of their first patient.
Read more